KONECT RESILIA aortic valved conduit

Built for bio-Bentall

KONECT RESILIA aortic valved conduit is the first and only pre-assembled, ready-to-implant^*bovine tissue AVC specifically designed for bio-Bentall procedures — offering a simplified, durable tissue^† alternative with a favorable safety profile.

^*Consult Instructions for Use for device preparation.
^†Clinical data on valves with RESILIA tissue up to 7-year follow-up have been published, with additional follow-up to 10-years in progress.¹

Simplifies the complex

Created to reduce complexity, KONECT RESILIA aortic valved conduit helps simplify your approach to root replacement. Its pre-assembled^* configuration helps reduce variability and promote standardization.^†2,3

^*Consult Instructions for Use for device preparation instructions.
^†As compared to self-assembled valved conduits.

A hand-sewn, secure hemostatic connection

Discover how KONECT RESILIA AVC compares to traditional self-assembled and mechanical conduits.

Reduce variability. Promote standardization.^*

KONECT RESILIA aortic valved conduit’s pre-assembled configuration helps minimize cross-clamp time.^*

Robust sewing ring profile

Hand sewn and precision-stitched with nearly 200 sutures used to assemble the graft to the valve stent. Designed with a wider hemostatic cuff to streamline the procedure and support anchoring to the aortic root.²

^*As compared to self-assembled valved conduits.

Experience the RESILIA tissue portfolio difference

Learn more

Explore the evidence

See our data

The Edwards Advantage

We are committed to providing your institution, clinicians and staff with the highest levels of customer service and support to ensure seamless product implementation and ongoing use, including:

24/7 Technical support

800.822.9837

For product information and orders

800.424.3278

Contact a sales representative

References

Beaver T, Bavaria JE, Griffith B, et al. Seven-year outcomes following aortic valve replacement with a novel tissue bioprosthesis. J Thorac Cardiovasc Surg. 2024;168(3):781-791. doi:10.1016/j.jtcvs.2023.09.047
Calderon-Rojas R, Bagameri G, Schaff HV, et al. Early experience with a prefabricated bioprosthetic aortic valved conduit: The first 100. JTCVS Open. 2025;26:34-43. Published 2025 Jun 6. doi:10.1016/j.xjon.2025.04.024
Podesser BK, De Paulis R. Implantability of a novel, pre-assembled aortic valved conduit with RESILIA™ tissue. J Cardiovasc Surg (Torino). 2020;61(3):376-379. doi:10.23736/S0021-9509.19.11022-1

Important Safety Information

KONECT RESILIA Aortic Valved Conduit

Indications: For use in replacement of native or prosthetic aortic heart valves and the associated repair or replacement of a damaged or diseased ascending aorta.

Contraindications: There are no known contraindications with the use of the KONECT RESILIA aortic valved conduit.

Complications and Side Effects: Thromboembolism, valve thrombosis, hemorrhage, hemolysis, regurgitation, endocarditis, structural valve deterioration, nonstructuraldysfunction, stenosis, arrhythmia, transient ischemic attack/stroke, congestive heart failure, myocardial infarction, any of which could lead to reoperation, explantation,permanent disability, and death. Adverse events potentially associated with the use of polyester vascular grafts include hemorrhage, thrombosis, graft infection, embolism,aneurysm, pseudoaneurysm, seroma, occlusion (anastomotic intimal hyperplasia), immunological reaction to collagen (shown to be a weak immunogen; infrequent, mild,localized and self-limiting), intimal peel formation, and conduit dilatation, any of which could lead to re-operation, explantation, permanent disability, and death.

CAUTION: US law restricts this device to sale by or on the order of a physician. See instructions for use for full prescribing information.